A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.4049/jimmunol.1600682
PubMed Identifier: 27881707
Publication URI: http://europepmc.org/abstract/MED/27881707
Type: Journal Article/Review
Volume: 198
Parent Publication: Journal of immunology (Baltimore, Md. : 1950)
Issue: 1
ISSN: 0022-1767